Sign inGet started

FRIEDMAN MICHAEL R.

Insider CIK 1993243 · GRTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GRTX Galera Therapeutics, Inc. D To issuer deriv2026-08-032026-08-05480— $00SEC↗
GRTX Galera Therapeutics, Inc. D To issuer2026-08-032026-08-0541,631— $00SEC↗
GRTX Galera Therapeutics, Inc. D To issuer deriv2026-08-032026-08-05480— —0SEC↗
GRTX Galera Therapeutics, Inc. D To issuer2026-08-032026-08-0541,631— —0SEC↗
GRTX Galera Therapeutics, Inc. C Conversion deriv2026-05-152026-08-052,989— $00SEC↗
GRTX Galera Therapeutics, Inc. C Conversion2026-05-152026-08-052,989,399— $08,326,269SEC↗
GRTX Galera Therapeutics, Inc. C Conversion deriv2026-05-152026-08-052,989— $00SEC↗
GRTX Galera Therapeutics, Inc. C Conversion2026-05-152026-08-052,989,399— —8,326,269SEC↗
GRTX Galera Therapeutics, Inc. C Conversion deriv2026-04-072026-04-095,337— $02,989SEC↗
GRTX Galera Therapeutics, Inc. C Conversion2026-04-072026-04-095,336,870— $05,336,870SEC↗
GRTX Galera Therapeutics, Inc. A Award deriv2025-02-242025-02-2696,000— $096,000SEC↗
GRTX Galera Therapeutics, Inc. A Award deriv2024-12-302025-01-028,326— $08,326SEC↗